Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Katrina A. Badiola"'
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e111782 (2014)
Tuberculosis afflicts an estimated 2 billion people worldwide and causes 1.3 million deaths annually. Chemotherapeutic solutions rely on drugs developed many years ago, with only one new therapeutic having been approved in the last 40 years. Given th
Externí odkaz:
https://doaj.org/article/32981c099fc943539bc32dd3ef2955d7
Autor:
Anthony F. Masters, Katrina A. Badiola, Thomas Maschmeyer, Hamidreza Arandiyan, Stuart A. Bartlett
Publikováno v:
European Journal of Inorganic Chemistry. 2018:3384-3387
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdd5a6fd9abac9bebffd72cce786db81
https://doi.org/10.1002/ejic.201800462
https://doi.org/10.1002/ejic.201800462
Autor:
Lourdes Encinas, Montserrat Ortega-Guerra, Ana Guardia, Joaquín Rullas, Esther Porras de Francisco, Juan Miguel-Siles, Cristina Rivero, Jorge Esquivias, Matthew H. Todd, Carlos Alemparte, Setshaba D. Khanye, Jessica Baiget, Raquel Vida Fernández, Winston Nxumalo, María Teresa Fraile-Gabaldón, Peter J. Rutledge, Esther Pérez-Herrán, Javier G. Osende, Modesto J. Remuiñán, Katrina A. Badiola, Marta León Alonso, Arancha Pérez, Ilaria Giordano, Elena Jimenez, Monica Cacho, Fátima Ortega
Publikováno v:
Journal of medicinal chemistry. 61(24)
Society urgently needs new, effective medicines for the treatment of tuberculosis. To kick-start the required hit-to-lead campaigns, the libraries of pharmaceutical companies have recently been evaluated for starting points. The GlaxoSmithKline (GSK)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2114d240443cf36d0bec882803efbb68
https://pubmed.ncbi.nlm.nih.gov/30457865
https://pubmed.ncbi.nlm.nih.gov/30457865
Autor:
Colin Leonard Bird, Martin C. Grossel, Luke Marazzi, Simon J. Coles, James R. Cronshaw, Matthew H. Todd, John Robinson, Brian Matthews, Danmar Gloria, Russell S. Minns, D. Brynn Hibbert, Rosanne Quinnell, Kelly A. Murphy, Erica Yang, Paul M. Ylioja, Richard T. Chapman, Karl T. Mueller, Lucy K. Mapp, William S. Brocklesby, Jeremy G. Frey, Adam L. Fisher, Graham J. Tizzard, Michael Robins, Cerys Willoughby, John Casson, Emma Springate, Katrina A. Badiola, Alice E. Williamson, Tim Parkinson, Nicola Knight, Andy Milsted, Murray N. Robertson
Publikováno v:
Chemical Science
Chemical scientists’ experiences with LabTrove.
Electronic Laboratory Notebooks (ELNs) are progressively replacing traditional paper books in both commercial research establishments and academic institutions. University researchers require spe
Electronic Laboratory Notebooks (ELNs) are progressively replacing traditional paper books in both commercial research establishments and academic institutions. University researchers require spe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b156a1f705762e46ed5830babfeba24
https://doi.org/10.1039/c4sc02128b
https://doi.org/10.1039/c4sc02128b
Autor:
Murray N. Robertson, Piero Olliaro, Paul M. Ylioja, Michael Woelfle, Paul Willis, Alice E. Williamson, Michael Robins, Matthew H. Todd, Timothy N. C. Wells, Katrina A. Badiola
Publikováno v:
Parasitology
SUMMARYOpen science is a new concept for the practice of experimental laboratory-based research, such as drug discovery. The authors have recently gained experience in how to run such projects and here describe some straightforward steps others may w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ced04e0425dace8c50fd5c0427adb777
https://doi.org/10.1017/s0031182013001121
https://doi.org/10.1017/s0031182013001121
Autor:
Katrina A. Badiola, Thomas Maschmeyer, Anthony F. Masters, Hamidreza Arandiyan, Stuart A. Bartlett
Publikováno v:
European Journal of Inorganic Chemistry. 2018:3356-3356
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d7a6c6a3becc81b4d64fc3f6022554a
https://doi.org/10.1002/ejic.201800833
https://doi.org/10.1002/ejic.201800833
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e111782 (2014)
PLoS ONE
PLoS ONE
Tuberculosis afflicts an estimated 2 billion people worldwide and causes 1.3 million deaths annually. Chemotherapeutic solutions rely on drugs developed many years ago, with only one new therapeutic having been approved in the last 40 years. Given th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::841f50c0915a71c20231a0e6c00b59f3
https://doi.org/10.1371/journal.pone.0111782
https://doi.org/10.1371/journal.pone.0111782